Nomad Bioscience GmbH Expands Customer-Tailored Services for Recombinant Protein Production

Nomad Bioscience GmbH Expands Customer-Tailored Services for Recombinant Protein Production

We are pleased to announce that Nomad Bioscience GmbH is expanding its customized services in the production of recombinant proteins using our proprietary green-plant-based expression platform. Our offerings include both expression and purification of proteins of interest, utilizing our well-established leaf-based transient expression systems: magnICON® and NOMADIC®, which have been extensively documented in peer-reviewed scientific literature.

Key Features of Our Platform:
• Rapid protein expression using transient systems
• High protein yields
• Broad ability to express various protein categories, including heterooligomers
• Multiple options for post-translational modifications
• Eukaryotic processing, including glycosylation
• Purification available with or without affinity tags
• Free from animal-derived components and animal/human pathogens
• Production of proteins that are difficult to express with other systems
• Comprehensive analytical and functional characterization available
• Delivery options: in solution or lyophilized form

For inquiries and collaboration opportunities, please contact us at:
info@nomadbioscience.com

Related articles

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain

NOMAD Bioscience Extends Agreements with Plant Biomass Producers in Extremadura Spain Munich, June, 2023 – NOMAD BIOSCIENCE GmbH, Munich, Germany…

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement

Nomad Bioscience and Fraunhofer Institute of Cell Therapy and Immunology Extend their Research and Development Agreement Nomad Bioscience GmbH, Munich,…

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins

NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins Munich, October 2022 – NOMAD Bioscience GmbH has…

NOMADS UAB, Lithuania Published a Milestone Research Paper Describing its Chimeric Bacteriocins for Control of Multidrug-Resistant Pseudomonas

NOMADS UAB, Lithuania Published a Milestone Research Paper Describing its Chimeric Bacteriocins for Control of Multidrug-Resistant Pseudomonas NOMADS UAB, Lithuania,…